Immunoradiotherapy for primary nonresectable hepatocellular carcinoma.
The ability to convert a nonrectable lesion into a resectable one offers significant palliation and possible cure for patients with hepatoma. With increasing effectiveness of radiolabeled immunoglobulin and multimodality treatment, more patients are expected to become candidates for definitive resection after presenting with unresectable disease.
Sitzmann
J V
JV
Johns Hopkins Hospital, Baltimore, Maryland.
Order
S E
SE
D006528:Carcinoma, Hepatocellular / Q000532:radiotherapy* / Q000601:surgery; D003131:Combined Modality Therapy; D005293:Ferritins / Q000276:immunology; D006801:Humans; D007074:Immunoglobulin G / Q000008:administration & dosage / Q000009:adverse effects; D007457:Iodine Radioisotopes / Q000008:administration & dosage / Q000627:therapeutic use; D008113:Liver Neoplasms / Q000532:radiotherapy* / Q000601:surgery; D015021:Yttrium Radioisotopes / Q000008:administration & dosage / Q000627:therapeutic use
D007074:Immunoglobulin G; D007457:Iodine Radioisotopes; D015021:Yttrium Radioisotopes; D005293:Ferritins